BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/24/2024 6:41:08 AM | Browse: 127 | Download: 303
 |
Received |
|
2024-04-29 01:02 |
|
Peer-Review Started |
|
2024-04-29 01:02 |
|
First Decision by Editorial Office Director |
|
2024-05-15 20:14 |
|
Return for Revision |
|
2024-05-15 20:14 |
|
Revised |
|
2024-05-28 20:39 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-07-02 02:45 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-07-02 06:12 |
|
Articles in Press |
|
2024-07-02 06:12 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-07-15 08:57 |
|
Publish the Manuscript Online |
|
2024-07-24 06:41 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Surgery |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Impact of neoadjuvant multimodal therapy in the setting of locally advanced hepatocellular carcinoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Daniele Ferraro, Federica Falaschi, Luca Nazzaro and Giovanni Vennarecci |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Daniele Ferraro, BSc, MD, Doctor, Doctor, Hepato-biliary and Liver Transplant Centre, Department of General Surgery and Woman’s Health, AORN Antonio Cardarelli, 9 Via Antonio Cardarelli, Naples 80131, Campania, Italy. daniele.ferraro.md@gmail.com |
| Key Words |
Hepatocellular carcinoma; Immunotherapy; Radioembolization; Chemoembolization; Liver transplantation; Liver resection |
| Core Tip |
The field of treatment for hepatocellular carcinoma is constantly evolving due to the advances in highly effective chemotherapeutic regimens. The possible use of drugs in the neoadjuvant setting as a powerful downstaging tool opens up the possibility of liver transplantation or liver resection for patients once deemed incurable. The use of these drugs in the adjuvant therapy setting could reinforce the results of surgery in the treatment of hepatocellular carcinoma. |
| Publish Date |
2024-07-24 06:41 |
| Citation |
Ferraro D, Falaschi F, Nazzaro L, Vennarecci G. Impact of neoadjuvant multimodal therapy in the setting of locally advanced hepatocellular carcinoma. World J Gastroenterol 2024; 30(28): 3452-3455 |
| URL |
https://www.wjgnet.com/1007-9327/full/v30/i28/3452.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v30.i28.3452 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
